Skip to main content
SpringerLink
Log in

Gastrointestinal Manifestations of Diabetes

  • Reference work entry
  • First Online:
Principles of Diabetes Mellitus

  • 3501 Accesses

Abstract

Gastrointestinal disorders are common in diabetic patients. While diabetic patients often suffer from the same gastrointestinal disorders as nondiabetic individuals, some conditions are more commonly seen in patients with diabetes. Enteric autonomic neuropathy is believed to be a major contributor to gastrointestinal symptoms as it may affect epithelial cells, muscles, or nerves. Damage and dysfunction may be acute and reversible or chronic and irreversible. There have been advances in the understanding and management of several conditions particularly prevalent in diabetic patients, such as esophageal dysmotility, gastroparesis, and constipation, due mainly to the development of improved techniques to assess and modulate neuromuscular function. Optimal management of a patient with diabetes mellitus includes preventing and treating a wide variety of gastrointestinal complaints beyond the management of glycemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Folwaczny C, Riepl R, Tschöp M, Landgraf R. Gastrointestinal involvement in patients with diabetes mellitus: part I (first of two parts). Epidemiology, pathophysiology, clinical findings. Z Gastroenterol. 1999;37:803–15.

    CAS  PubMed  Google Scholar 

  2. Chen P, Zhao J, Gregersen H. Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats. Dig Dis Sci. 2012;57:48–57.

    Article  CAS  PubMed  Google Scholar 

  3. Nowak TV, Harrington B, Weisbruch JP, Kalbfleisch JH. Structural and functional characteristics of muscle from diabetic rodent small intestine. Am J Physiol. 1990;258:G690–8.

    CAS  PubMed  Google Scholar 

  4. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res. 2001;56:1–21.

    Article  CAS  PubMed  Google Scholar 

  5. Sánchez SS, Genta SB, Aybar MJ, Honoré SM, Villecco EI, Sánchez Riera AN. Changes in the expression of small intestine extracellular matrix proteins in streptozotocin-induced diabetic rats. Cell Biol Int. 2000;24:881–8.

    Article  PubMed  Google Scholar 

  6. Zoubi SA, Mayhew TM, Sparrow RA. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites. Virchows Arch. 1995;426:501–7.

    Article  CAS  PubMed  Google Scholar 

  7. Zoubi SA, Williams MD, Mayhew TM, Sparrow RA. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition. Virchows Arch. 1995;427:187–93.

    Article  CAS  PubMed  Google Scholar 

  8. Talley NJ, Bytzer P, Hammer J, et al. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol. 2001;96:1033–8.

    Article  CAS  PubMed  Google Scholar 

  9. Frokjaer JB, Andersen SD, Ejskjaer N, Funch-Jensen P, Drewes AM, Gregersen H. Impaired contractility and re-modeling of the upper gastrointestinal tract in diabetes mellitus type-1. World J Gastroenterol. 2007;13:4881–90.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Darwazeh AM, MacFarlane TW, McCuish A, et al. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med. 1991;20(6):280–3.

    Article  CAS  PubMed  Google Scholar 

  11. Loo FD, Dodds WJ, Soergel KH, et al. Multipeaked esophageal peristaltic pressure waves in patients with diabetic neuropathy. Gastroenterology. 1985;88:485–91.

    Article  CAS  PubMed  Google Scholar 

  12. Faraj J, Melander O, Sundkvist G, Olsson R, Thorsson O, Ekberg O, Ohlsson B. Oesophageal dysmotility, delayed gastric emptying and gastrointestinal symptoms in patients with diabetes mellitus. Diabet Med. 2007;24:1235–9.

    Article  CAS  PubMed  Google Scholar 

  13. Keshavarzian A, Iber FL, Nasrallah S. Radionuclide esophageal emptying and manometric studies in diabetes mellitus. Am J Gastroenterol. 1987;92:625–31.

    Google Scholar 

  14. Gustafsson RJ, Littorin B, Berntorp K, Frid A, Thorsson O, Olsson R, et al. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud. 2011;8:268–75.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rayner CK, Samsom M, Jones KL, et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care. 2001;224:371–81.

    Article  Google Scholar 

  16. Horowitz M, Edelbroek M, Fraser R, Maddox A, Wishart J. Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol. 1991;26:673–84.

    Article  CAS  PubMed  Google Scholar 

  17. Choung RS, Locker GR, et al. Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population. Am J Gastroenterol. 2012;107:34–42.

    Article  Google Scholar 

  18. Rey E, Choung RS, Schleck CD, et al. Prevalence of hidden gastroparesis in the community: the gastroparesis “iceberg’. J Neurogastroenterol Motil. 2012;18:34–42.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Parkman HP, Yates K, Hasler WL, et al. Clinical features of idiopathic gastroparesis vary with sex, body mass, symptom onset, delay in gastric emptying and gastroparesis severity. Gastroenterology. 2011;140:101–15.

    Article  PubMed  Google Scholar 

  20. Hasler WL, Wilson L, Parkman HP, et al. Importance of abdominal pain as a symptom in gastroparesis: relation to clinical factors, disease severity, quality of life, gastric retention, and medication use. Gastroenterology. 2010;138 Suppl 1:S461.

    Google Scholar 

  21. Cherian D, Parkman HP. Nausea and vomiting in diabetic and idiopathic gastroparesis. Neurogastroenterol Motil. 2012;24:217. e103.

    Article  CAS  PubMed  Google Scholar 

  22. Koch KL. Dyspepsia of unknown origin: pathophysiology, diagnosis and treatment. Dig Dis. 1997;15:316–29.

    Article  CAS  PubMed  Google Scholar 

  23. Mearin F, Camilleri M, Malagelada J-R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90:1919–25.

    Article  CAS  PubMed  Google Scholar 

  24. Khoo J, Rayner CK, Jones KL, et al. Pathophysiology and management of gastroparesis. Expert Rev Gastroenterol Hepatol. 2009;3:167–81.

    Article  CAS  PubMed  Google Scholar 

  25. Grover M, Bernard CE, Pasricha PJ, et al. Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research consortium. Neurogastroenterol Motil. 2012;24:531–9.

    Article  CAS  PubMed  Google Scholar 

  26. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear medicine. Am J Gastroenterol. 2008;103:753–63.

    Article  PubMed  Google Scholar 

  27. Pathikonda M, Sachdeva P, Malhorta N, Fisher RS, Maeurer AH, Parkmean HP. Gastric emptying scintigraphy: is four hours necessary? J Clin Gastroenterol. 2012;46:209–15.

    Article  PubMed  Google Scholar 

  28. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2008;103:18–37.

    Google Scholar 

  29. Richard JS, William LW. A technical review and clinical assessment of the wireless motility capsule. Gastroenterol Hepatol. 2011;7:795–804.

    Google Scholar 

  30. Kuo B, McCallum RW, Koch KL, et al. Comparison of gastric emptying of a nondigestible capsule to a radiolabelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2008;27:186–96.

    Article  CAS  PubMed  Google Scholar 

  31. Wang Q, Ito M, Adams K, et al. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome. Am J Med Genet A. 2004;131:50–8.

    Article  PubMed  Google Scholar 

  32. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87:114–19.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C, et al. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab. 2008;294:E846–52.

    Article  CAS  PubMed  Google Scholar 

  34. Vella A, Bock G, Giesler PD, et al. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007;56:1475–80.

    Article  CAS  PubMed  Google Scholar 

  35. FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs. FDA 26 February 2009. Available at: http://www.fda.gov/newevents/newsroom/pressan-nouncements/ucm149533.htm.

  36. Rossi M, Giorgi G. Domperidone and long QT syndromes. Curr Drug Saf. 2010;5:257–62.

    Article  CAS  PubMed  Google Scholar 

  37. Asakawa A, Ueno N, Katagi M, Ijuin Y, Morita Y, Mizuno S, Inui T, Sakamaki R, Shinfuku N, Uemoto M. Mosapride improves food intake, while not worsening glycemic control and obesity, in ob/ob obese mice with decreased gastric emptying. J Diabetes Complications. 2006;20:56–8.

    Article  PubMed  Google Scholar 

  38. Kawamura E, Enomoto M, Kotani K, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Kawabe J, Tominaga K, Tamori A, Shiomi S, Kawada N. Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesis. Dig Dis Sci. 2012;57:1510–6.

    Article  CAS  PubMed  Google Scholar 

  39. Barrett TW, DiPersio DM, Jenkins CA, et al. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011;29:247–55.

    Article  PubMed  Google Scholar 

  40. Chong K, Dhatariya K. A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant. Nat Rev Endocrinol. 2009;5:285–8.

    Article  PubMed  Google Scholar 

  41. Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53:1566–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Prakash C, Lustman PJ, Freedland KE, et al. Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci. 1998;43:1951–6.

    Article  CAS  PubMed  Google Scholar 

  43. Sawhney MS, Prakash C, Lustman PJ, et al. Tricyclic antidepressants for chronic vomiting in diabetic patients. Dig Dis Sci. 2007;52:418–24.

    Article  CAS  PubMed  Google Scholar 

  44. Lustman PJ, Griffith LS, Clouse RE, et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med. 1997;59:241–50.

    Article  CAS  PubMed  Google Scholar 

  45. Kim SW, Shin IS, Kim JM, et al. Mirtazapine for severe gastroparesis unresponsive to conventional prokinetic treatment. Psychosomatics. 2006;47:440–2.

    Article  PubMed  Google Scholar 

  46. Sarosiek I, Davis B, Eichler E, McCallum RW. Surgical approaches to treatment of gastroparesis: gastric electrical stimulation, pyloroplasty, total gastrectomy and enteral feeding tubes. Gastroenterol Clin North Am. 2015;44:151–67.

    Article  PubMed  Google Scholar 

  47. Hirata A, Kishida K, Nakatsuji H, Inoue K, Hiuge-Shimizu A, Funahashi T, Shimomura I. High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome. Nutr Metab (Lond). 2012;9:4.

    Article  CAS  Google Scholar 

  48. Sharma P, McQuaid KR, Dent J, et al. A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago workshop. Gastroenterology. 2004;127:310–30.

    Article  PubMed  Google Scholar 

  49. Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease. World J Gastroenterol. 2005;11:4291–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Wilson JA, Vela MF. New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance. Curr Gastroenterol Rep. 2008;10:222–30.

    Article  PubMed  Google Scholar 

  51. del Genio G, Tolone S, del Genio F, et al. Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring. J Gastrointest Surg. 2008;12:1491–6.

    Article  PubMed  Google Scholar 

  52. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer a meta-analysis. J Am Med Assoc. 1995;273:1605–9.

    Article  CAS  Google Scholar 

  53. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer a meta-analysis of 36 studies. Br J Cancer. 2005;92:2076–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Fisher WE, Boros LG, Schirmer WJ. Insulin promotes pancreatic cancer evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996;63:310–3.

    Article  CAS  PubMed  Google Scholar 

  55. Schneider MB, Matsuzaki H, Haorah J, et al. Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology. 2001;120:1263–70.

    Article  CAS  PubMed  Google Scholar 

  56. Bell ET. Carcinoma of the pancreas. I. A. clinical and pathological study of 609 necropsied cases II. The relation of carcinoma of the pancreas to diabetes. Am J Pathol. 1957;33:499.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. Stone BG, Gavaler JS, Belle SH, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology. 1988;95:170–6.

    Article  CAS  PubMed  Google Scholar 

  58. Upp JR, Nealon WH, Singh P, et al. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg. 1987;205:641–8.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Keshavarzian A, Iber FL. Intestinal transit in insulin-requiring diabetics. Am J Gastroenterol. 1986;81:257–60.

    CAS  PubMed  Google Scholar 

  60. Cuzick J, Babiker AG. Pancreatic cancer, alcohol, diabetes mellitus, and gallbladder disease. Int J Cancer. 1989;43:415–21.

    Article  CAS  PubMed  Google Scholar 

  61. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis. 1995;6:187.

    CAS  PubMed  Google Scholar 

  62. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993;68:691–702.

    Article  CAS  PubMed  Google Scholar 

  63. Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med. 1985;102:197–9.

    Article  CAS  PubMed  Google Scholar 

  64. Von der Ohe MR, Camilleri M, Thomforde GM, et al. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 1995;36:743–8.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Lee TH, Lee JS. Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time. Korean J Intern Med. 2013;28:106–7.

    Article  PubMed  Google Scholar 

  66. Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4:51–63.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Battle WM, Snape WR, Alavi A, et al. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980;79:1217–21.

    CAS  PubMed  Google Scholar 

  68. Lysy J, Karmeli F, Sestieri M, et al. Decreased substance P content in the rectal mucosa of diabetics with diarrhea and constipation. Metabolism. 1997;46:730–34.

    Article  CAS  PubMed  Google Scholar 

  69. Russo A, Botten R, Kong MF, Chapman IM, Fraser RJ, Horowitz M, Sun WM. Effects of acute hyperglycaemia on anorectal motor and sensory function in diabetes mellitus. Diabet Med. 2004;21:176–82.

    Article  CAS  PubMed  Google Scholar 

  70. Whitehead WE, Rao SS, Lowry A, Nagle D, Varma M, Bitar KN, Bharucha AE, Hamilton FA. Treatment of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases workshop. Am J Gastroenterol. 2015;110:138–46.

    Article  PubMed  Google Scholar 

  71. Wald A, Tunuguntla K. Anorectal sensorimotor dysfunction, fecal incontinence and diabetes mellitus. N Engl J Med. 1984;310:1282–7.

    Article  CAS  PubMed  Google Scholar 

  72. Carrington EV, Evers J, Grossi U, Dinning PG, Scott SM, O'Connell PR, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil. 2014;26:1222–37.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Liver Diseases, Mount Sinai St. Luke’s and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, 1111 Amsterdam Av. S&R 12, New York, NY, USA

    Donald P. Kotler

  2. 4290 Crosswinds Drive, 18045, Easton, PA, USA

    Zheng Lin

  3. Division of Gastroenterology and Liver Diseases, Mount Sinai St. Luke’s and Mount Sinai West Hospitals, 1111 Amsterdam Av. S&R 12, New York, NY, USA

    Il J. Paik

  4. Gastroenterology, Princeton HealthCare System, Princeton, New Jersey, USA

    Stanley Hsu

Authors
  1. Donald P. Kotler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zheng Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Il J. Paik
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stanley Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Gerald J. Friedman Diabetes Institute, Lenox Hill Hospital, Hofstra Northwell School of Medicine, Northwell Health, New York, New York, USA

    Leonid Poretsky

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Kotler, D.P., Lin, Z., Paik, I.J., Hsu, S. (2017). Gastrointestinal Manifestations of Diabetes. In: Poretsky, L. (eds) Principles of Diabetes Mellitus. Springer, Cham. https://doi.org/10.1007/978-3-319-18741-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18741-9_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18740-2

  • Online ISBN: 978-3-319-18741-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation